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Abstract  The  IgG4-related  disease  (IgG4-RD)  is  a  recurrent  chronic  ﬁbroinﬂammatory  disease,
probably of  autoimmune  origin,  recently  recognised.  Its  diagnosis  is  based  on  a  combination  of
clinical, radiological,  serological,  histopathological  and  immunohistochemical  data.  However,
the histopathology  is  considered  as  the  golden  ‘‘standard’’  for  diagnosis.  In  most  of  the  cases,
the sum  of  lymphoplasmacytic  inﬂammatory  inﬁltrate  with  abundant  IgG4+  plasma  cells,  stori-
form ﬁbrosis  and  obliterative  phlebitis  makes  a  reliable  diagnosis.  Patients  usually  show  elevated
serum IgG4  concentrations  and  respond  well  to  steroid  therapy.  Nowadays,  IgG4-RD  has  been
described in  almost  every  organ:  pancreatobiliary  tract,  liver,  salivary  glands,  nasopharynx,
bone marrow,  lacrimal  gland,  extra-ocular  muscles  and  retrobulbar  space,  kidney,  lung,  lymph
nodes, meninges,  aorta,  skin,  breast,  prostate,  thyroid  gland  and  pericardium.
© 2013  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
S.A. All  rights  reserved.
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Algunos  aspectos  histopatológicos  de  la  enfermedad  relacionada  con  IgG-4
Resumen  La  enfermedad  relacionada  con  IgG-4  (ERIgG-4)  es  una  enfermedad  ﬁbroinﬂama-
toria crónica  recurrente,  probablemente  de  origen  autoinmune,  reconocida  recientemente,
cuyo diagnóstico  se  basa  en  una  combinación  de  datos  clínicos,  radiológicos,  serológicos,
histopatológicos  y  de  inmunohistoquímica.  Sin  embargo  la  histopatología  se  reconoce  como
el ‘‘standard’’  de  oro  para  el  diagnóstico;  la  suma  de  inﬁltrado  inﬂamatorio  linfoplasmocitario
con abundantes  células  plasmáticas  IgG4+,  ﬁbrosis  esteriforme  y  ﬂebitis  obliterativa  permite
hacer un  diagnóstico  conﬁable  en  la  mayoría  de  los  casos.  Los  pacientes  frecuentemente  pre-
sentan concentraciones  elevadas  de  IgG4  sérica  y  responden  muy  bien  a  la  terapia  esteroidea.
ito  ERIgG4  casi  en  todos  los  órganos:  tracto  pancreatobiliar,  hígado,En la  actualidad  se  ha  descrE-mail address: minervalao@yahoo.com.mx
http://dx.doi.org/10.1016/j.hgmx.2015.03.007
0185-1063/© 2013 Sociedad Médica del Hospital General de México. Published by Masson Doyma México S.A. All rights reserved.
100  M.  Lazos-Ochoa
glándulas  salivales,  nasofaringe,  médula  ósea,  glándula  lacrimal,  músculos  extra-oculares  y
espacio retrobulbar,  rin˜ón,  pulmón,  ganglios  linfáticos,  meninges,  aorta,  piel,  mama,  próstata,
tiroides y  pericardio.
©  2013  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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pThe  IgG4-related  disease  (IgG4-RD)  is  a  recurrent  chronic
broinﬂammatory  disease,  probably  of  autoimmune  origin,
ecently  recognised.  Its  diagnosis  is  based  on  a  combination
f  clinical,  radiological,  serological,  histopathological  and
mmunohistochemical  data.  Nowadays,  IgG4-RD  has  been
escribed  in  almost  every  organ:  pancreatobiliary  tract,
iver,  salivary  glands,  nasopharynx,  bone  marrow,  lacrimal
land,  extra-ocular  muscles  and  retrobulbar  space,  kidney,
ung,  lymph  nodes,  meninges,  aorta,  skin,  breast,  prostate,
hyroid  gland  and  pericardium.1
IgG4-RD  was  initially  identiﬁed  in  the  pancreas  and  was
alled  autoimmune  pancreatitis  (AIP).  Although  it  was  made
ublic  in  1961,  the  ﬁrst  description  of  the  AIP  histopatholog-
cal  data  was  published  in  19912,3 and  in  2001  it  was  related
o  high  levels  of  serum  IgG4.4 The  observation  that  patients
ith  AIP  have  ﬁbroinﬂammatory  injuries  rich  in  IgG4  plasma
ells  +  extrapancreatic  cells  led  to  the  IgG4-RD  concept  in
003.5 During  the  following  years,  the  spectrum  of  the  dis-
ase  broadened  to  include  bile  ducts,  retroperitoneum  and
alivary  glands.  Besides,  it  was  recognised  that  the  extra-
ancreatic  injuries  can  precede,  coexist  or  appear  after  the
IP  diagnosis.  Nowadays,  diseases  such  as  Mikulicz’s  disease,
üttner’s  tumour,  multifocal  ﬁbrosclerosis,  inﬂammatory
seudotumour,  Riedel’s  thyroiditis,  aorta’s  inﬂammatory
neurysm,  cutaneous  pseudolymphoma  and  angiocentric
brosis  are  considered  part  of  the  IgG4-RD  spectrum.
The  IgG4-RD  nomenclature  has  evolved  and  has  been
nown  as  IgG4-related  systemic  disease,  IgG4-related  scle-
osing  disease,  IgG4-related  autoimmune  disease,  hyper-
gG4  disease  and  IgG4  syndrome,  among  others.  In  2011,  an
nternational  committee,  comprising  35  clinicians,  pathol-
gists  and  radiologists,  gathered  in  Boston,  Massachusetts
rimarily  to  establish  norms  for  the  histopathological  crite-
ia  for  the  disease  diagnosis.6 In  2012,  a  group  of  Japanese
nvestigators  suggested  the  name  IgG4-RD,  which  has  been
ccepted.  The  increase  in  serum  IgG4  concentrations  is  use-
ul  in  suspecting  the  IgG4-RD  diagnosis,  although  they  are
either  enough  nor  necessary.  Patients  can  have  increases  up
o  25  times  the  normal  IgG4  values  in  serum,  or  even  higher;
ut  between  20%  and  40%  have  normal  concentrations  even
hen  they  show  classical  histopathological  criteria  of  the
isease.7 Serum  IgG4  concentrations  tend  to  be  higher  in
atients  with  multiple  organ  involvement,  and  they  are  not
ndicators  of  disease  activity  or  response  to  treatment.  On
he  contrary,  patients  who  are  going  through  the  last  stages
f  the  disease,  when  sclerosis  is  the  prevailing  histological
atum,  tend  to  show  low  IgG4  concentrations.  The  increase
n  serum  IgG4  concentrations  is  not  exclusively  linked  to
gG4-RD.  There  are  other  diseases  such  as  atopic  dermatitis,
arasitary  infections,  pemphigus  vulgaris,  pemphigus  foli-
ceus  and  pancreatic  carcinoma  which  also  show  increases
n  this  protein.8
i
T
(IgG4  is  the  less  common  Ig  subclass,  encompassing
pproximately  between  3%  and  6%  of  the  entire  IgG  frac-
ion.  It  is  unique  due  to  its  ability  to  join  C1q,  and  therefore
t  cannot  activate  the  classical  pathway  of  complement
ctivation.9
The  IGg4-RD  physiopathology  is  not  clear  yet.  The  dis-
ase  can  result  in  a  hypersensitivity  reaction/allergy  or  be
f  autoimmune  origin.  Some  studies  indicate  that  it  is  pro-
uced  biphasically.  The  initial  stage  is  induced  as  a  response
owards  autoantigens  such  as  carbonic  anhydrase  and  lacto-
errine  as  a result  of  the  decrease  of  regulatory-natural  T
ells.  Besides,  the  activation  of  cooperative  T  cells  type
 releases  proinﬂammatory  cytokines  like  interleukin  10,
esponsible  for  increasing  serum  IgG4  concentrations  and
timulating  plasma  cells,  which  produce  this  immunoglob-
lin.  The  second  stage  is  a  result  of  a  greater  activation
mount  of  memory  regulatory  T  cells  and  type  2  coopera-
ive  T  cells,  which  explains  the  chronic  inﬂammation.  The
nﬂammatory  inﬁltrate  is  formed  by  a  mix  of  T  and  B  cells,
ith  an  increase  in  T  CD4+,  CD  25+,  and  FOXP3+  cells.  The
ytokines  produced  by  the  type  2  cooperative  lymphocytes
interleukine  4,  interleukine  5  and  interleukine  13)  and  reg-
latory  cytokines  (interleukine  10  and  transforming  growth
actor)  are  overegulated  in  the  involved  tissues.  Another
ypothesis  suggests  an  increase  in  the  type  2  cooperative
 cells  response  before  the  gut  microﬂora  or  an  immune
esponse  based  on  the  presence  of  immune  complex  deposits
n  the  basal  membranes  of  the  pancreatic  acini  and  renal
ubules.8,10
Patients  with  IgG4-RD  are  usually  men  over  50  years  and
end  to  form  nodular  injuries  in  organs.  These  pseudotu-
ours  are  usually  misdiagnosed  as  malignant  neoplasias,
ommonly  affecting  the  orbit,  salivary  glands,  lung,  kid-
ey,  lymph  nodes,  retroperitoneum  and  other  organs.  The
iffuse  inﬁltrative  disease  was  described  in  the  meninges,
kin,  aorta  or  peripheral  nerves.  In  some  cases,  only  one  or
wo  organs  are  affected,  and  in  other  cases  there  is  multi-
le  organ  involvement.11 Multiple  organ  injuries  can  appear
ynchronously  or  metachronously.12 In  the  series  with  higher
umber  of  cases  (114),  published  so  far  by  Zen  et  al.,  31%
f  them  showed  systemic  or  multiple  organ  disease;  24%
howed  pancreatobiliary  disease;  in  20%  the  disease  was
ocated  in  head  and  neck;  14%  showed  thoracic  disease  and
1%  retroperitoneal  disease.10
Patients  with  IgG4-RD  commonly  have  history  of  aller-
ic  rhinitis,  sinusitis,  asthma  and  other  allergic  or  atopic
iseases.  Some  patients  show  serum  IgE  increases  and
eripheral  eosinophilia.
This  disease  has  an  indolent  clinical  course  with  man-
festations  which  can  take  months  or  years  to  appear.
he  diagnosis  takes  around  13.5  months  to  be  made
4--60  months).13 Most  of  the  patients  often  show  general
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collagenosis,  inﬂammatory  myoﬁbroblastic  tumour  and
some  carcinomas  can  present  an  increase  in  the  number
of  positive  IgG4  plasma  cells.16,17 Today  it  is  recommended
that  a  quantitative  analysis  of  the  positive  plasma  cells
in  the  different  organs  be  made  and  compared  with  the
cut  points  established  by  the  experts  in  2012.16,17 The  cut
points  vary  from  over  10  positive  plasma  cells  in  pancreas,
liver  or  kidney  biopsies  to  over  200  in  cutaneous  biopsies.
However,  it  is  important  to  emphasise  that  the  number  of
positive  cells  should  not  be  used  as  an  isolated  diagnostic
criterion,  because  there  are  cases  in  which  a  diagnosis
with  a  low  amount  of  positive  IgG4  plasma  cells  is  made,
particularly  when  there  is  advanced  sclerosis.
Some  investigators  have  suggested  that  if  the  proportion
between  IgG4+  and  IgG+  plasma  cells  is  higher  than  40%,  the
IgG4-RD  diagnosis  can  be  made.14 However,  this  datum  was
not  considered  sufﬁcient  IgG4-RD  pathological  evidence  at
the  experts’  consensus  whose  conclusions  were  published
by  Deshpande  in  2012.17 There  are  cases  that  show  IgG4/IgG
proportions  >50%  without  the  histopathological  criteria,  for
instance,  conditions  in  which  there  are  high  interleukine  6
serum  concentrations,  as  in  rheumatoid  arthritis  and  Castle-
man  disease.18
The  combination  of  common  histopathological  data  and
a  high  number  of  IgG4+  plasma  cells  is  the  gold  standard
for  diagnosis;  however,  in  the  appropriate  context,  there  is
enough  evidence  to  make  the  IgG4-RD  clinical-pathological
diagnosis  in  the  tissue  examination  that  only  shows  some
data.19 Speciﬁc  terminology  was  suggested  for  the  IgG4-
RD  diagnosis,  including  3  categories:  (a)  Highly  suggestive
IgG4-RD  histological  data  with  at  least  2  out  of  3  his-
tological  data,  IgG4+  plasma  cell  count  according  to  the
established  parameters18 and  IgG4+/IgG+  proportion  >40%,
(b)  Histological  data  of  probable  IgG4-RD  cases  with  only  a
histopathological  datum  (generally  lymphocitary  inﬂamma-
tory  inﬁltrate)  and  appropriate  count  of  IgG4+  plasma  cells.
Clinical,  radiological  and  serological  evidence  is  required
in  these  cases  to  conﬁrm  the  diagnosis.  This  evidence  canFigure  1  Storiform  ﬁbrosis  associated  to  lymphoplasmacytic
inﬂammatory  inﬁltrate.  100×  Masson  staining.
symptoms  and  usually  feel  well  despite  having  a  systemic
disease.  However,  a  small  group  of  subjects  have  an  acute
disease  characterised  by  general  symptoms,  fever  and
serum  increase  in  acute  phase  reactants.6
IgG4-RD  diagnosis  not  only  requires  a  characteristic
histopathological  appearance  but  also  a  high  number  of
IgG4+  plasma  cells.  The  three  histopathological  criteria
are:  lymphoplasmacytic  inﬂammatory  inﬁltrate,  ﬁbrosis
arranged,  at  least  focally,  in  storiform  pattern  (Fig.  1)  and
obliterative  phlebitis  (Fig.  2).  These  changes  cause  atro-
phy  and  loss  of  the  specialised  structures  from  the  different
tissues.14 The  tissues  show  similar  changes  regardless  of  the
involved  organ.1,15
At  the  beginning,  it  was  believed  that  the  number  of
IgG4+  plasma  cells  was  a  highly  speciﬁc  marker  of  the
disease;  however,  it  is  now  known  that  this  ﬁnding  is
unspeciﬁc.  Diseases  such  as  ANCA-associated  vasculitis,
rheumatoid  arthritis,  inﬂammatory  bowel  disease,  Rosai-
Dorfman  disease,  autoimmune  atrophic  gastritis,  Castleman
disease,  primary  sclerosing  cholangitis,  reactive  perforating
Figure  2  Pancreas  with  obliterative  phlebitis.  100×  elastic
ﬁbres  staining.
include:  serum  IgG4  >  135  mg/dl  and  another  organ  involve-
ment  proved  radiologically  or  pathologically,  (c)  Insufﬁcient
histological  data  for  the  IgG4-RD  diagnosis:  the  biopsies  in
this  category  show  lymphoplasmacytic  inﬂammatory  inﬁl-
trate  without  an  increase  in  the  number  of  plasma  cells  or
ﬁbrosis  without  storiform  pattern16,17 (Table  1).
Table  1  Terminology  for  the  IgG4-RD  histological  diagnosis.
Highly  suggestive  IgG4-RD  histological  data
2 out  of  3  histological  data
IgG4+  plasma  cells
IgG4+/IgG+  cells  proportion  >  40%
Histological  data  of  likely  IgG4-RD
1 histological  datum
IgG4+  plasma  cells
Serum  IgG4>  135  mg/dl  or  other  organ  involvement,
radiologically  or  anatomopathologically  proven
Insufﬁcient  histological  data  for  the  IgG4-RD  diagnosis
Lymphoplasmacytic  inﬂammatory  inﬁltrate
IgG4− plasma  cells
Fibrosis  without  storiform  pattern
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branes.  Those  patients  with  MGN  associated  to  IgG4  show
urine  protein  in  nephritic  ranges;  in  them,  glomerulopathy
is  secondary  to  the  deposit  of  immune  complexes  and  notFigure  3  Lungs  with  nodular  lesions  in  both  upper  lobes.
The  involvement  of  the  thyroid  gland  as  part  of  the  IgG4-
D  spectrum  is  increasingly  recognised  because  some  of  the
atients  present  hypothyroidism  and  high  levels  of  antithy-
oglobulin  antibodies.  Riedel’s  thyroiditis  was  also  identiﬁed
s  an  IgG4-RD  manifestation.20 The  thyroid  biopsies  of  those
atients  in  whom  the  disease  is  new  show  characteristic
istopathological  data  and  ﬁbrosis  when  the  IgG4-RD  has
volved.  Recently,  a  variant  of  Hashimoto’s  thyroiditis  which
s  part  of  the  IgG4-RD  spectrum  was  described  and  can  be
he  cause  of  the  hypothyroidism  appearing  in  some  of  these
atients.21
The  lymphadenopathy  related  to  IgG4-RD  can  appear
efore,  together  with  or  after  the  diagnosis  of  the  disease.
lthough  several  ganglionic  groups  are  generally  affected,
redominantly  the  mediastinal,  abdominal  and  axillary,
atients  do  not  usually  show  general  symptoms;  but  they  can
ave  polyclonal  hypergammaglobulinaemia,  serum  IgG4  con-
entrations  and  increase  in  serum  IgE  and  IgG.  It  is  common
o  take  biopsies  in  these  cases  with  presumptive  diagnoses
f  lymphoma,  Castleman  disease  or  metastasic  lymphomas.
he  histopathology  is  considerably  variable  in  these  cases;
 patterns  were  described:  (I)  similar  to  Castleman  disease,
II)  follicular  hyperplasia,  (III)  interfollicular  expansion,  (IV)
rogressive  transformation  of  the  germinal  centres  and  (V)
imilar  to  inﬂammatory  pseudotumour.  A  high  number  of
gG4  cells  is  observed  in  every  pattern  and  the  IgG4+/IgG
roportion  is  >40%.8,22,23
Approximately  half  of  the  patients  with  pulmonary  dis-
ase  related  to  IgG4  show  cough,  haemoptysis,  dyspnoea,
leural  effusion  and  chest  pain.  In  other  patients,  the  dis-
ase  is  asymptomatic  and  it  is  only  discovered  through  image
canning.  There  are  6  morphological  patterns  described
rom  the  radiological  and  histopathological  point  of  view:
1)  nodules  (Fig.  3),  (2)  hilar  enlargement,  (3)  inter-
titial/alveolar  disease  with  honeycomb  pattern,  diffuse
mages  in  ground-glass  and  bronchiectasis,  (4)  round  opac-
ties  in  ground-glass,  (5)  thickening  or  pleural  effusion  and
6)  extrinsic  compression  of  the  upper  airways  by  ﬁbrosing
ediastinitis.8,22,24
F
ligure  4  Decreased  pancreas  size  with  a  sclerosing  injury  in
he tail.
The  symptomatology  of  patients  with  AIP  differs  from  the
ymptomatology  of  those  who  suffer  from  other  types  of
ancreatitis,  particularly  the  alcoholic  type.  These  patients
sually  have  obstructive  jaundice,  loss  of  weight  and  mild
r  moderate  abdominal  discomfort.  These  clinical  data,
ogether  with  the  radiological  ones,  such  as  occupative
asses,  frequently  determine  the  suspicion  of  pancreatic
arcinoma  diagnosis  (Fig.  4).  Most  of  the  cases  are  diag-
osed  by  the  characteristic  tomographic  ﬁndings  described
s  ‘‘sausage-shaped  pancreas’’  and  are  conﬁrmed  through
iopsy  with  a  thin  needle  or  through  endoscopic  retrograde
holangiopancreatography.8,22,25
The  IgG4-RD  can  also  involve  the  kidneys  and  the  urinary
ract.  In  the  kidneys,  the  most  common  symptom  is  the  tubu-
ointerstitial  nephritis  (TIN);  only  7%  of  the  patients  with
enal  failure  have  membranous  glomerulonephritis  (MGN).
ost  of  the  patients  with  tubulointerstitial  nephritis  have
cute  or  progressive  renal  failure.  It  appears  as  renal  mass
n  some  patients  and  both  appear  in  other  patients.  Approx-
mately  80%  of  the  patients  with  TIN  have  an  increase  in  the
gG  or  IgG4  serum  levels.  Other  common  laboratory  ﬁnd-
ngs  are  the  decrease  in  the  C3  and  C4  levels,  peripheral
osinophilia,  urine  protein,  microscopic  haematuria  and  low
evels  of  antinuclear  antibodies.  From  the  radiological  point
f  view,  injuries  are  usually  bilateral,  multiple  and  predom-
nant  in  the  cortex,  even  though  diffuse  nephromegaly  can
lso  be  observed  (Fig.  5).  In  the  biopsy  or  nephroctomy,  lym-
hoplasmacytic  inﬂammatory  inﬁltrate  rich  in  IgG4+  plasma
ells,  ﬁbrosis  and  tubular  atrophy  is  observed.  The  presence
f  IgG4  deposits  was  proven  in  the  tubular  basal  mem-igure  5  External  surface  of  the  kidneys  that  show  light  yel-
ow nodules  of  cortical  prevalence.
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Figure  6  Submandibular  gland  replaced  by  light  yellow  tissue
Table  2
Place  Alteration
Thyroid  Riedel’s  thyroiditis
Lymph  node I.  Similar  to  the  Castleman  disease
II.  Follicular  hyperplasia
III.  Interfollicular  expansion
IV. Transformation  of  germinal
centres
V. Similar  to  inﬂammatory
pseudotumour
Lung  I.  Nodules
II.  Hilar  enlargement
III.  Interstitial/alveolar  disease
IV.  Opacities  in  ground-glass
V  Thickening  or  pleural  effusion
VI. Fibrosing  mediastinitis
Kidney  I.  Tubulointerstitial  nephritis
II.  Membranous  glomerulonephritis
Retroperitoneal  I.  Retroperitoneal  ﬁbrosis
II. Aortic  inﬂammatory  aneurysm
III. Retroperitoneal  and  aortic
affection
Salivary  gland  Sclerosis  sialadenitis  (Küttner
tumour)
m
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2003;98:2811--2.(Küttner  tumour).
a  consequence  of  the  inﬂammatory  process  which  charac-
terises  the  IgG4-RD.8,22,26
The  retroperitoneal  ﬁbrosis  is  one  of  the  IgG4-RD  man-
ifestations.  The  abdominal  aorta  is  usually  involved  in  this
condition  and  it  can  adopt  two  macroscopic  patterns:  one  in
the  form  of  nodules  or  masses,  and  another  in  the  form  of
plaques.  Based  on  the  sites  affected  by  this  form  of  dis-
ease,  it  can  be  classiﬁed  as:  (1)  retroperitoneal  ﬁbrosis,
(2)  inﬂammatory  aneurysm  of  the  aorta,  (3)  a  combina-
tion  of  retroperitoneal  and  aortic  involvement  and  (4)  chest
aortitis.8,22,27
Most  of  the  cholecystitis  cases  related  to  IgG4  are  asymp-
tomatic  and  were  found  incidentally.  Approximately  25%  of
the  AIP  cases  are  associated  to  lymphoplasmacytic  acal-
culous  cholecystitis  rich  in  IgG4+  cells  with  predominantly
extramural  involvement.8,22
The  IgG4-RD  of  the  salivary  glands  is  shown  as  hard  uni-
lateral  or  bilateral  tumoural  masses  which  are  frequently
confused  with  neoplasic  injuries.  The  patients  are  adults
with  an  average  age  of  60  years,  men  being  slightly  pre-
dominant.  In  most  of  the  cases,  the  submandibular  gland  is
affected  (Fig.  6).  In  the  bilateral  cases,  the  disease  is  gen-
erally  asynchronous,  even  though  it  can  be  metachronous.
Allergic  rhinitis  and  asthma  are  common  in  these  patients,
and  they  usually  have  peripheral  eosinophilia  and  high  levels
of  serum  IgG  and  antinuclear  antibodies.  Most  of  the  patients
show  an  increase  in  the  serum  IgG4;  however,  up  to  40%  can
show  normal  levels  of  this  immunoreactant.28
Patients  with  ocular  annexes  affection  show  similar  ﬁnd-
ings  to  the  salivary  gland  affection.  Its  average  age  is  50
years;  but  there  is  no  predominant  genre.  They  appear
with  oedema  or  elevated  painless  unilateral  or  bilateral,
periorbital  or  palpebral  volume.  A  small  number  of  them
show  diplopia  or  proptosis;  however,  visual  acuity  is  rarely
affected.  The  disease  affects  the  lacrimal  glands  and  the
periorbital  soft  tissues.  It  rarely  affects  the  conjunctiva28
(Table  2).
In the  last  years,  great  progress  has  been  achieved
regarding  the  IgG4-RD  understanding;  but  much  is  still
unknown  about  the  clinical-pathological  manifestations  of
the  IgG4-RD.  The  diagnosis  not  only  requires  the  presence  of
characteristic  histopathological  data  but  also  the  elevated
IgG4.  The  correlation  between  the  clinical,  radiological  andOcular  annexes  I.  Sclerosing  dacriodenitis
II. Periorbitary  ﬁbrosis
icroscopic  data  is  essential  to  arrive  at  the  appropriate
iagnosis.
Most  of  the  studies  of  this  disease  come  from  Asia,  and  it
s  unknown  whether  there  are  clinical  or  pathological  differ-
nces  with  the  cases  of  western  countries.  There  are  some
ymphoma  cases  associated  with  IgG4-RD;  but  more  studies
re  required  to  conﬁrm  the  possibility  of  a  higher  risk  to
uffer  from  lymphoma  in  patients  with  IgG4-RD.
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